skip to contentNational Cancer Institute
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Skip navigation
In a video message during the July 2010 meeting of the DCLG in Seattle, Washington, NCI Director Dr. Harold Varmus outlines opportunities for the advocacy community to engage in cancer research. In a July 2010 video message to the DCLG  for their meeting in Seattle, Washington, NCI Director Dr. Harold Varmus outlines opportunities for the advocacy community to engage in cancer research. Watch the video.

The NCI Director's Consumer Liaison Group is a Federal Advisory Committee comprising advocate leaders, chosen for their expert understanding of the perspectives and dynamics of the cancer research community. The DCLG identifies and responds to issues and challenges facing the Institute at the request of the Director. The DCLG provides relevant non-scientific skills and perspectives in order to improve research outcomes by identifying new approaches, promoting innovation, recognizing unforeseen risks or barriers, and identifying unintended consequences that could result from NCI decisions. Attend a DCLG meeting to see how the DCLG is involved in these areas.

The Advocates in Research Working Group (ARWG) was created under the auspices of the DCLG to provide NCI with recommendations for involving advocates across the spectrum of NCI activities in ways that will accelerate progress, benefit patients, and improve public health. The final ARWG Executive Summary and Recommendations are now available.